The New Born Eye Imaging Systems Market is estimated to be valued at USD 239.4 million in 2025 and is projected to reach USD 416.7 million by 2035, registering a compound annual growth rate (CAGR) of 5.7% over the forecast period.
The newborn eye imaging systems market is witnessing steady growth driven by the increasing focus on early diagnosis and treatment of neonatal eye conditions. Clinical research and healthcare initiatives have highlighted the importance of screening premature infants to prevent vision impairment caused by conditions such as retinopathy of prematurity.
Advances in imaging technology have made eye screening more accessible, faster, and less invasive for newborns. Hospitals and neonatal care centers are expanding their use of these imaging systems to improve clinical outcomes through timely intervention.
Regulatory encouragement for standardized neonatal screening programs and rising awareness among healthcare providers and parents are further supporting market expansion. The growth is also propelled by increasing neonatal intensive care unit capacities globally. Looking forward, innovations that improve image resolution, portability, and integration with telemedicine platforms are expected to shape future developments. Segment growth is expected to be driven by retinopathy of prematurity as the primary disease focus, basic devices as the preferred device type, and hospitals as the leading end user.
The market is segmented by Disease Type, Device Type, and End-User and region. By Disease Type, the market is divided into Retinopathy of prematurity, Ocular development, Refractive state, Strabismus, Visual functions, Visual acuity, Visual fields, and Colour vision. In terms of Device Type, the market is classified into Basic Device and Wireless Device.
Based on End-User, the market is segmented into Hospital, Ophthalmology Diagnosis Centre, Ambulatory Surgical Centre, and Other. Regionally, the market is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.
The retinopathy of prematurity segment is projected to hold 33.7% of the newborn eye imaging systems market revenue in 2025, leading disease categories. This segment’s growth is driven by the high prevalence of the condition in premature infants, which can lead to blindness if undetected. The need for early diagnosis to prevent severe complications has increased demand for reliable imaging solutions.
Hospitals and neonatal units have incorporated routine screening protocols to identify retinopathy early and initiate timely treatment. Awareness campaigns by healthcare organizations have emphasized the importance of monitoring at-risk newborns, contributing to greater screening uptake.
The segment benefits from technological improvements that allow non-invasive and detailed retinal imaging even in fragile infants. As premature birth rates remain significant worldwide, retinopathy of prematurity will continue to be a key focus for eye imaging systems.
The basic device segment is expected to contribute 58.4% of the newborn eye imaging systems market revenue in 2025, establishing itself as the dominant product type. Basic devices are favored due to their ease of use, affordability, and suitability for routine screening in hospital settings.
These devices typically offer sufficient imaging quality for initial diagnosis while being compact and easy to operate by clinical staff. Their cost-effectiveness supports widespread adoption, especially in resource-constrained healthcare facilities.
The segment has been propelled by growing neonatal care infrastructure expansion and efforts to standardize eye screening protocols. Manufacturers have focused on improving device portability and usability to facilitate bedside imaging in neonatal intensive care units. The basic device segment’s prominence reflects its role as the primary tool for early detection and ongoing monitoring of neonatal eye conditions.
The hospital segment is projected to hold 45.6% of the newborn eye imaging systems market revenue in 2025, maintaining its leading position among end users. Hospitals are the primary settings for newborn screening and treatment, equipped with specialized neonatal care units that utilize eye imaging systems for comprehensive eye health management.
Increasing hospital investments in neonatal care technologies and infrastructure have supported the integration of these imaging devices into routine clinical workflows. The segment benefits from established referral networks and multidisciplinary teams focused on infant health.
Additionally, hospitals play a crucial role in training healthcare professionals and standardizing screening procedures, which has increased the consistent use of imaging systems. The growing focus on reducing infant morbidity and preventing long-term vision loss continues to drive hospital adoption of newborn eye imaging systems.
It is projected that there is a rapid rise in the number of babies that are suffering from eye problems across the world, and it is serving to be one of the primary factors driving the growth and demand for the new born eye imaging systems.
The newborn eye imaging systems are highly adopted because it works on a simple process, and the tool is used for the identification of the problem for treatment.
Moreover, in newborn babies, the ROP (Retinopathy of Prematurity) is the main reason for vision loss; ROP also affects the blood vessels and spreads via the retina, which is fueling the demand in the new born eye imaging systems market.
Furthermore, the ratio of affected-born babies is likely to fuel the market to come up with more advanced products in the market.
In addition to that, it is anticipated that there is a rapidly increasing approval for the new born eye imaging systems from the respective organizations and rapid technological advancements by various market players, which is further accelerating the expansion of the new born eye imaging systems market size and are also offering significant growth opportunities for the market during the forecast period of 2025 to 2035.
It is anticipated that there is very less awareness about the new born eye imaging systems in the market, which is likely to hinder the growth of this product market.
In addition to that, there is a high cost involved in the usage of new born eye imaging systems. One of the key restraining factors that are to curb the growth of the new born eye imaging market is the dearth of trained professionals.
Furthermore, there is increasing adoption of refurbished imaging systems that have the potential to challenge the growth of the new born eye imaging systems and influence the market share for new born eye imaging systems.
It is projected that North American regions are likely to lead the new born eye imaging systems market. It is currently accountable for 35.8% of the total new born eye imaging systems market share.
The growth of the new born eye imaging systems market is owing to the strong presence of the major market players in this region.
Furthermore, there is an increasing number of new born population that is suffering from eye problems in this region, and are looking for minimally invasive procedures to overcome the issues. It has been revealed, for instance, according to Centers for Disease Control and Prevention in October 2020, one in every 33 babies is affected from eye borne diseases.
Europe is anticipated to follow North America, and is currently accountable for 25.3% of the total market share for new born eye imaging systems market.
The market in European regions has the potential to influence the global new born eye imaging systems market as the government of this region is directly involved in the treatment of eye diseases, hence leading to significant growth of the market size in the upcoming years.
How are New Entrants Revolutionizing the New Born Eye Imaging Systems Market?
The start-up ecosystem in the new born eye imaging systems market is intense with frequent innovations being made. Start-ups in the new born eye imaging systems market are focusing on improvising the tools for better implementation of devices in the new born populace.
The Palo Alto startup has developed an AI-based system that can screen the retinal images of newborn babies to highlight potential eye conditions that require follow-up and treatment.
Remido Innovative Solutions is another start-up providing cures to new born babies. Remidio is developing more sophisticated devices to revolutionize the new born eye imaging systems market and fuel the growth further during the forecast period.
Who are some of the Key Market Players in the New Born Eye Imaging Systems Market?
Some of the biggies in the new born eye imaging systems market include ;D-EYE S.r.l., Natus Medical Incorporated, SERVICOM MEDICAL (SINGAPORE) PTE LTD., Visunex Medical Systems, Inc., IBM, Remidio Innovative Solutions, System Vision SA, Allied Vision Technologies GmbH, Leica Microsystems, Canon Medical Systems, USA., Carl Zeiss Meditec AG, Intelligent Retinal Imaging Systems, Nikon Corporation, Kowa American Corporation, Topcon Europe Medical BV, NextSight, Veatch Ophthalmic Instruments, Boston Micromachines Corporation, Thales Group and Imagine Eyes.
The various market players in the new born eye imaging systems market are looming with advanced devices and technologies for imaging purposes as well as raising funds for research activities which are also largely contributing to the growth in the global market over the forecast period of 2025 to 2035.
Key Developments in the New Born Eye Imaging Systems Market
Some of the key developments in the new born eye imaging systems market are:
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 5.7% from 2025 to 2035 |
| Base Year for Estimation | 2024 |
| Historical Data | 2020 to 2024 |
| Forecast Period | 2025 to 2035 |
| Quantitative Units | Revenue in USD million and CAGR from 2025 to 2035 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered | Disease Type, Device Type, End User, Region |
| Regions Covered | North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East and Africa |
| Key Countries Profiled | USA, Canada, Brazil, Argentina, Germany, UK, France, Spain, Italy, Nordics, BENELUX, Australia &, New Zealand, China, India, ASEAN, GCC, South Africa |
| Key Companies Profiled | D-EYE S.r.l., Natus Medical Incorporated, SERVICOM MEDICAL (SINGAPORE) PTE LTD., Visunex Medical Systems, Inc., IBM, Remidio Innovative Solutions, System Vision SA, Allied Vision Technologies GmbH, Leica Microsystems, Canon Medical Systems, USA., Carl Zeiss Meditec AG, Intelligent Retinal Imaging Systems, Nikon Corporation, Kowa American Corporation, Topcon Europe Medical BV, NextSight, Veatch Ophthalmic Instruments, Boston Micromachines Corporation, Thales Group, Imagine Eyes |
| Customization | Available Upon Request |
The global new born eye imaging systems market is estimated to be valued at USD 239.4 million in 2025.
It is projected to reach USD 416.7 million by 2035.
The market is expected to grow at a 5.7% CAGR between 2025 and 2035.
The key product types are retinopathy of prematurity, ocular development, refractive state, strabismus, visual functions, visual acuity, visual fields and colour vision.
basic device segment is expected to dominate with a 58.4% industry share in 2025.
Explore Similar Insights
New Born Eye Imaging Systems Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Chat With
MaRIA
